Grantham, Mayo, Van Otterloo & Co (GMO)’s Molina Healthcare MOH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio MOH Stock Details MOH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$246K	Buy	+1,075	New	+$195K	﹤0.01%	623
2026 Q1	–	Sell	-24,815	Closed	-$4.31M	–	689
2025 Q4	$4.31M	Sell	24,815 -18,387	-43%	-$3.02M	0.01%	329
2025 Q3	$8.27M	Buy	43,202 +41,002	+1,864%	+$7.55M	0.02%	252
2025 Q2	$655K	Sell	2,200 -2,057	-48%	-$646K	﹤0.01%	521
2025 Q1	$1.4M	Buy	+4,257	New	+$1.29M	﹤0.01%	401
2024 Q3	–	Sell	-9,065	Closed	-$2.7M	–	584
2024 Q2	$2.7M	Buy	+9,065	New	+$3.08M	0.01%	347
2019 Q2	–	Sell	-28,800	Closed	-$4.09M	–	749
2019 Q1	$4.09M	Buy	28,800 +20,600	+251%	+$2.79M	0.03%	297
2018 Q4	$953K	Buy	+8,200	New	+$1.07M	0.01%	362

Other funds holding MOH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s MOH Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) opened a new position in Molina Healthcare (MOH) in Q2 2026: 1,075 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #623 among its holdings. This is a return to the name: Grantham, Mayo, Van Otterloo & Co (GMO) previously reported a position in MOH as recently as Q4 2025.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in MOH in Q4 2018 and has held it in 8 quarters since. The position peaked at $8.27M in Q3 2025. 601 funds tracked by Wall St. Rank hold MOH as of Q2 2026.

Grantham, Mayo, Van Otterloo & Co (GMO) held 1,075 shares of Molina Healthcare worth $246K as of Q2 2026.
Molina Healthcare was a new Grantham, Mayo, Van Otterloo & Co (GMO) position in Q2 2026.
Molina Healthcare made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #623 holding.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Molina Healthcare in Q4 2018 and has held it in 8 quarters since.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Molina Healthcare position peaked at $8.27M in Q3 2025.
601 funds tracked by Wall St. Rank held Molina Healthcare as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.